Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid

J Orthop Surg Res. 2019 Apr 4;14(1):95. doi: 10.1186/s13018-019-1117-x.

Abstract

Background: Nitrogen-containing bisphosphonates (BIS) are potent therapeutics in osteoporosis, but their use may result in osteonecrotic side-effects in the maxillofacial region. Periosteal microcirculatory reactions may contribute to the development of bone-healing complications, particularly in osteoporotic bones, where ischemia-reperfusion (IR) events often develop during orthopaedic/trauma interventions. The effect of BIS on the inflammatory reactions of appendicular long bones has not yet been evaluated; thus, we aimed to examine the influence of chronic zoledronate (ZOL) administration on the periosteal microcirculatory consequences of hindlimb IR in osteopenic rats.

Materials and methods: Twelve-week-old female Sprague-Dawley rats were ovariectomized (OVX) or sham-operated, and ZOL (80 μg/kg iv, weekly) or a vehicle was administered for 8 weeks, 4 weeks after the operation. At the end of the pre-treatment protocols, 60-min limb ischemia was induced, followed by 180-min reperfusion. Leukocyte-endothelial interactions were quantitated in tibial periosteal postcapillary venules by intravital fluorescence videomicroscopy. CD11b expression of circulating polymorphonuclear leukocytes (PMN, flow cytometry) and plasma TNF-alpha levels (ELISA) were also determined. Two-way RM ANOVA followed by the Holm-Sidak and Dunn tests was used to assess differences within and between groups, respectively.

Results: Limb IR induced significant increases in PMN rolling and firm adhesion in sham-operated and OVX rats, which were exacerbated temporarily in the first 60 min of reperfusion by a ZOL treatment regimen. Postischemic TNF-alpha values showed a similar level of postischemic elevations in all groups, whereas CD11b expression only increased in rats not treated with ZOL.

Conclusions: The present data do not show substantial postischemic periosteal microcirculatory complications after chronic ZOL treatment either in sham-operated or OVX rats. The unaltered extent of limb IR-induced local periosteal microcirculatory reactions in the presence of reduced CD11b adhesion molecule expression on circulating PMNs, however, may be attributable to local endothelial injury/activation caused by ZOL.

Keywords: Bisphosphonate; Inflammation; Intravital microscopy; Leukocytes; Periosteum.

MeSH terms

  • Animals
  • Bone Density Conservation Agents / pharmacology*
  • Bone Diseases, Metabolic / blood
  • Bone Diseases, Metabolic / drug therapy
  • CD11b Antigen / blood
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology
  • Female
  • Hindlimb / blood supply*
  • Microcirculation / drug effects*
  • Neutrophils / drug effects
  • Neutrophils / physiology
  • Ovariectomy
  • Periosteum / blood supply
  • Periosteum / drug effects
  • Rats, Sprague-Dawley
  • Reperfusion Injury / blood
  • Reperfusion Injury / physiopathology*
  • Zoledronic Acid / pharmacology*

Substances

  • Bone Density Conservation Agents
  • CD11b Antigen
  • Zoledronic Acid